Home › NDC Lookup › RxCUI directory › RxCUI 1242705

Hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet [Nulev] — RxCUI 1242705

RxNorm drug concept · Semantic branded drug
RxCUI 1242705 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1242705
Official nameHyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet [Nulev]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asNulev 0.125 MG Disintegrating Oral Tablet
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)26 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Hyoscyamine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
📖 Read our full Hyoscyamine guide →

🕸️ Concept Web — How Hyoscyamine sulfate 0.125 MG Disintegrating Oral... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet [Nulev] RxCUI 1242705

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Hyoscyamine 153970
    • Hyoscyamine sulfate 1225
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Nulev 284812
  3. Dose forms 17

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Hyoscyamine Disintegrating Oral Tablet 370665
    • Hyoscyamine sulfate Disintegrating Oral Tablet 2646116
    • Hyoscyamine Disintegrating Oral Product 1294826
    • Hyoscyamine Oral Product 1165278
    • Hyoscyamine Pill 1165279
    • Hyoscyamine sulfate Disintegrating Oral Product 2663241
    • Hyoscyamine sulfate Oral Product 2659505
    • Hyoscyamine sulfate Pill 2661552
    • +9 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 23 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet SCD · 1046985
  • Hyoscyamine sulfate 0.125 MG SCDC · 1046981
  • Hyoscyamine Disintegrating Oral Tablet SCDF · 370665
  • Hyoscyamine sulfate Disintegrating Oral Tablet SCDFP · 2646116
  • Hyoscyamine Disintegrating Oral Product SCDG · 1294826
  • Hyoscyamine Oral Product SCDG · 1165278
  • Hyoscyamine Pill SCDG · 1165279
  • Hyoscyamine sulfate Disintegrating Oral Product SCDGP · 2663241
  • Hyoscyamine sulfate Oral Product SCDGP · 2659505
  • Hyoscyamine sulfate Pill SCDGP · 2661552

Brand-Name Concepts

  • Hyoscyamine sulfate 0.125 MG [Nulev] SBDC · 1048070
  • Hyoscyamine Disintegrating Oral Tablet [Nulev] SBDF · 1855460
  • Hyoscyamine sulfate Disintegrating Oral Tablet [Nulev] SBDFP · 2657655
  • Nulev Disintegrating Oral Product SBDG · 1855461
  • Nulev Oral Product SBDG · 1178805
  • Nulev Pill SBDG · 1178806
  • Nulev BN · 284812

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1242705 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68220-0118-10 100 TABLET, CHEWABLE in 1 BOTTLE (68220-118-10) NuLev Viatris Specialty LLC 2008-12-01
Observed labelers: Viatris Specialty LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.1772
Range $0.1772–$0.1772 · middle 50% $0.1772–$0.1772 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.